Top

Drugs

Published in:

01-11-2007 | Adis Drug Profile

Continuous-Use Ethinylestradiol/Levonorgestrel 20µg/90µg as an Oral Contraceptive

A Viewpoint by Paula Bednarek

Author: Paula Bednarek

Published in: Drugs | Issue 16/2007

Excerpt

Since the introduction of oral contraceptives (OCs) >40 years ago, OC formulations have included 21 active and 7 placebo tablets per 28-day cycle to produce a monthly withdrawal bleed. …

Edelman AB, Gallo MF, Jensen JT, et al. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev 2005; (3): CD004695

Title: Continuous-Use Ethinylestradiol/Levonorgestrel 20µg/90µg as an Oral Contraceptive
A Viewpoint by Paula Bednarek
Author: Paula Bednarek
Publication date: 01-11-2007
Publisher: Springer International Publishing
Published in: Drugs / Issue 16/2007
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI: https://doi.org/10.2165/00003495-200767160-00010

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Continuous-Use Ethinylestradiol/Levonorgestrel 20µg/90µg as an Oral Contraceptive

A Viewpoint by Paula Bednarek

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 16/2007

Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg

Estrogen Receptor Modulators and Down Regulators

Pathophysiology and Management of Opioid-Induced Pruritus

Salmeterol/Fluticasone Propionate

Multidrug-Resistant Streptococcus pneumoniae Infections

Hormone Therapy for the Prevention of Bone Loss in Menopausal Women with Osteopenia